ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Phase I study of weekly paclitaxel and liposomal doxorubicin in patients with advanced solid tumours
European Journal of Cancer
◽
10.1016/s0959-8049(02)00168-5
◽
2002
◽
Vol 38
(15)
◽
pp. 1992-1997
◽
Cited By ~ 13
Author(s):
N Androulakis
◽
C Kouroussis
◽
D Mavroudis
◽
S Kakolyris
◽
J Souglakos
◽
...
Keyword(s):
Phase I
◽
Phase I Study
◽
Liposomal Doxorubicin
◽
Solid Tumours
◽
Weekly Paclitaxel
Download Full-text
Related Documents
Cited By
References
Phase I study of weekly paclitaxel and liposomal doxorubicin in patients with advanced solid tumours
European Journal of Cancer
◽
10.1016/s0959-8049(01)80759-0
◽
2001
◽
Vol 37
◽
pp. S75
Author(s):
N. Androulakis
◽
Ch. Kouroussis
◽
D. Mavroudis
◽
S. Agelaki
◽
J. Souglakos
◽
...
Keyword(s):
Phase I
◽
Phase I Study
◽
Liposomal Doxorubicin
◽
Solid Tumours
◽
Weekly Paclitaxel
Download Full-text
Phase I study of bortezomib with weekly paclitaxel in patients with advanced solid tumours
European Journal of Cancer
◽
10.1016/j.ejca.2008.05.022
◽
2008
◽
Vol 44
(13)
◽
pp. 1829-1834
◽
Cited By ~ 21
Author(s):
S. Cresta
◽
C. Sessa
◽
C.V. Catapano
◽
E. Gallerani
◽
D. Passalacqua
◽
...
Keyword(s):
Phase I
◽
Phase I Study
◽
Solid Tumours
◽
Weekly Paclitaxel
Download Full-text
A Phase I Study of Daily Afatinib, an Irreversible Erbb Family Blocker, Combined With Weekly Paclitaxel and 2-Weekly Bevacizumab in Patients with Advanced Solid Tumours
Annals of Oncology
◽
10.1016/s0923-7534(20)33023-4
◽
2012
◽
Vol 23
◽
pp. ix161
Author(s):
D. Enting
◽
J.E. Ang
◽
C. O'Hanlon-Brown
◽
R. Kristeleit
◽
M. Uttenreuther-Fischer
◽
...
Keyword(s):
Phase I
◽
Phase I Study
◽
Solid Tumours
◽
Weekly Paclitaxel
◽
Erbb Family
◽
Erbb Family Blocker
Download Full-text
Phase I study of olaparib in combination with liposomal doxorubicin in patients with advanced solid tumours
British Journal of Cancer
◽
10.1038/bjc.2014.345
◽
2014
◽
Vol 111
(4)
◽
pp. 651-659
◽
Cited By ~ 58
Author(s):
G Del Conte
◽
C Sessa
◽
R von Moos
◽
L Viganò
◽
T Digena
◽
...
Keyword(s):
Phase I
◽
Phase I Study
◽
Liposomal Doxorubicin
◽
Solid Tumours
Download Full-text
A phase I study of daily afatinib, an irreversible ErbB family blocker, in combination with weekly paclitaxel in patients with advanced solid tumours
European Journal of Cancer
◽
10.1016/j.ejca.2015.07.041
◽
2015
◽
Vol 51
(16)
◽
pp. 2275-2284
◽
Cited By ~ 14
Author(s):
A. Suder
◽
J.E. Ang
◽
F. Kyle
◽
D. Harris
◽
S. Rudman
◽
...
Keyword(s):
Phase I
◽
Phase I Study
◽
Solid Tumours
◽
Weekly Paclitaxel
◽
Erbb Family
◽
Erbb Family Blocker
Download Full-text
Ambulatory 4-day continuous-infusion schedule of high-dose ifosfamide with mesna uroprotection and granulocyte colony-stimulating factor in advanced solid tumours: A phase I study
Annals of Oncology
◽
10.1093/oxfordjournals.annonc.a059118
◽
1995
◽
Vol 6
(2)
◽
pp. 193-196
◽
Cited By ~ 16
Author(s):
S. Toma
◽
R. Palumbo
◽
A. Comandone
◽
C. Oliva
◽
M. Vincenti
◽
...
Keyword(s):
Phase I
◽
Continuous Infusion
◽
Phase I Study
◽
Solid Tumours
◽
High Dose
◽
Granulocyte Colony Stimulating Factor
◽
Colony Stimulating Factor
◽
Infusion Schedule
◽
Stimulating Factor
Download Full-text
Intravenous administration of CP-4055 (ELACYT™) in patients with solid tumours. A phase I study
Acta Oncologica
◽
10.1080/02841860802183620
◽
2009
◽
Vol 48
(1)
◽
pp. 137-145
◽
Cited By ~ 19
Author(s):
Svein Dueland
◽
Steinar Aamdal
◽
Michael J. Lind
◽
Hilary Thomas
◽
Marit Liland Sandvold
◽
...
Keyword(s):
Phase I
◽
Intravenous Administration
◽
Phase I Study
◽
Solid Tumours
Download Full-text
Phase I study of JAK1/2 inhibitor ruxolitinib with weekly paclitaxel for the treatment of HER2-negative metastatic breast cancer
Cancer Chemotherapy and Pharmacology
◽
10.1007/s00280-021-04245-x
◽
2021
◽
Author(s):
Filipa Lynce
◽
James T. Williams
◽
Meredith M. Regan
◽
Craig A. Bunnell
◽
Rachel A. Freedman
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase I
◽
Phase I Study
◽
Metastatic Breast
◽
Weekly Paclitaxel
Download Full-text
33O A phase I study to evaluate safety, pharmacokinetics (PK), and preliminary efficacy of CYH33, a phosphatidylinositol 3-kinase α (PI3Kα) inhibitor, in patients (pts) with advanced solid tumours
Annals of Oncology
◽
10.1016/j.annonc.2021.01.048
◽
2021
◽
Vol 32
◽
pp. S14
Author(s):
X-L. Wei
◽
J-H. Liu
◽
H. Zhao
◽
Y. Zhang
◽
Q-W. Liu
◽
...
Keyword(s):
Phase I
◽
Phase I Study
◽
Solid Tumours
◽
Phosphatidylinositol 3 Kinase
◽
Phosphatidylinositol 3
Download Full-text
Phase I study of axitinib and everolimus in metastatic solid tumours and extension to metastatic renal cell carcinoma: Results of EVAX study
European Journal of Cancer
◽
10.1016/j.ejca.2017.07.031
◽
2017
◽
Vol 85
◽
pp. 39-48
◽
Cited By ~ 1
Author(s):
Alain Ravaud
◽
Carlos Gomez-Roca
◽
Marie-Quitterie Picat
◽
Laurence Digue
◽
Christine Chevreau
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Phase I
◽
Cell Carcinoma
◽
Metastatic Renal Cell Carcinoma
◽
Renal Cell
◽
Phase I Study
◽
Solid Tumours
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close